Health

Asia Agri-Tech Expo & Forum 2020 announces date change to 5-7 November

TAIPEI, Jan. 10, 2020 /PRNewswire/ -- Asia Agri-Tech Expo & Forum 2020 changes its dates for new labour policies at Taipei Nangang Exhibition Center, Hall 1 from 5th to 7th November 2020, and will be co-located with Aquaculture Taiwan and Livestock Taiwan. The 3-in-1 event has moved one day ahead...

2020-01-10 09:20 3398

Jorjin and Gigabyte Join Forces to Showcase a Smart Pharmacy Solution and a New Family of AR Smart Glasses at CES 2020

LAS VEGAS, Jan. 9, 2020 /PRNewswire/ -- Jorjin Technologies, who started working on smart glasses when AR was still in its infancy, will be partnering with Gigabyteat this year's CES on a joint AR-based end-to-end solution for Smart Pharmacies. Furthermore, Jorjin will also introduceJ-Ability, th...

2020-01-10 02:15 1124

Led by Taiwan Tech Arena, LuftQi Is Committed to Developing Non-Consumable Nano Photocatalytic Purification Technology to Improve Air Quality and Health

LAS VEGAS, Jan. 9, 2020 /PRNewswire/ -- LuftQi and other notable homegrown startups led by Taiwan Tech Arena (TTA) are now showcasing their innovative solutions at CES 2020. With the nano photocatalytic purification technology, the Luft Cu...

2020-01-10 00:30 1968

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio(TM)

SANTA CLARA, Calif., Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 North American Technology Innovation Award for its Cala Trio™, a prescription-only, wrist-worn d...

2020-01-09 22:00 905

WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

* The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global o...

2020-01-09 17:10 2213

Alma, a Sisram Medical Company, Launches DermaClear 3-in-1 Skin Hydradermabrasion Platform

NUREMBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced the launch of DermaClear, a powerful 3-in-1 treatment solution for deep cleansing, nourishment, and hydration of facial skin.   DermaClear i...

2020-01-09 17:00 1480

The largest full marathon in China:The 2020 C&D Xiamen Marathon starts

XIAMEN, China, Jan. 9, 2020 /PRNewswire/ -- "Falling in love with a city while running". The 2020 C&D Xiamen Marathon started at7:30 a.m. on January 5, with 35,071 runners having qualified, and 29,805 of them joining the event in the flesh. Runners from 41 countries and regions participated in th...

2020-01-09 16:11 1170

FHA-Food & Beverage spotlights tech innovation and industry transformation in new FoodTech Zone

SINGAPORE, Jan. 9, 2020 /PRNewswire/ -- From novel farming methods to connected kitchens, thetechnological and investment potential in the food tech space has grown dynamically in recent years. InSingapore...

2020-01-09 12:03 2726

Alma, a Sisram Medical Company, Receives Excellence Award for "Outstanding Business Performance in Japan"

NURNBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced it has been recognized with an Excellence Award for its "outstanding business performance inJapan" in 2019. The annual "Excellence Award" was...

2020-01-09 10:00 1203

Daewoong Infion obtained World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells

SEOUL, South Korea, Jan. 9, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals.  World's First Halal certification for Biopharmaceutical Product derived from An...

2020-01-09 09:51 2728

Publication of a Toxicological Study: A Milestone for Jennewein Biotechnologie for the GRAS Approval of the HMO-mix

RHEINBREITBACH, Germany, Jan. 9, 2020 /PRNewswire/ -- Jennewein Biotechnology announces another milestone in the worldwide approval of a new product generation, the "HMO-Mix." The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats," w...

2020-01-09 02:26 2221

Symmetry Surgical, Inc. Acquires The O.R. Company

Acquisition strengthens Symmetry's commitment to deliver best-in-class, cost-effective solutions NASHVILLE, Tennessee, Jan. 9, 2020 /PRNewswire/ -- Symmetry Surgical, Inc. ("Symmetry"), is pleased to announce that it has completed its acquisition of The O.R. Company. The O.R. Company develops, m...

2020-01-09 00:37 1169

Waters Corporation Lauded by Frost & Sullivan for Developing the First Truly Smart Mass Spectrometer, the BioAccord LC-MS System

The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Based on its analysis of the global biopharmaceutical analytical instrumentation market, Frost & Sullivan ...

2020-01-08 21:30 6127

Transcenta Holding Secures $100 Million Series B Plus Financing

HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...

2020-01-08 21:00 1322

Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors

SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the appointment of Mr.Mark J. Alles as an independent director of the company, effectiveJanuary 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiar...

2020-01-08 20:00 2777

Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201

Data show superior efficacy after four weeks of treatment and more rapid onset of action for CBP-201 compared with data from studies of current standard of care therapy for AD On Day 29, 42.9% and 50.0% of patients receiving CBP-201 300 mg or 150 mg, respectively, achieved "clear/almost clear" s...

2020-01-08 19:00 906

CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma

SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients wit...

2020-01-08 13:45 2677

Daewoong Pharmaceutical Receives World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Daewoong Infion

SEOUL, South Korea, Jan. 8, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. Daewoong Pharmaceutical Co., Ltd. (CEO Sengho Jeon) announced that Daewoong Infion, the company's joint venture with Infion, an In...

2020-01-08 11:00 1136

Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers

* HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies * Study, published in Molecular Cancer Therapeutics, found HMBD-001 to be able to uniquely block HER3 dimerization interface and potently inhibit tumor growth SINGAPORE, Jan. 8, 2020 /PR...

2020-01-08 10:40 732

Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US

SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, and Sirnaomics Inc. ("Si...

2020-01-08 08:00 8715
1 ... 735736737738739740741 ... 814